Price Alert

Milestone Pharmaceuticals... (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.70

0.02 (1.19%)

At close: Aug 15, 2025, 3:59 PM

1.67

-1.47%

After-hours: Aug 15, 2025, 07:57 PM EDT

Milestone Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	45.09M	25.31M	12.8M	13.26M	10.13M	13.76M	9.88M	32.59M	73.95M	7.64M	37.29M	63.24M	92.24M	114.14M	111.43M	97.79M	71.86M
Short-Term Investments	10.87M	44.38M	63.62M	69.99M	79.35M	52.24M	65.87M	55M	27M	56.95M	39.95M	23M	8M	n/a	15M	38M	58M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.45M	n/a	-2.68M	-2.85M	-797K	n/a	n/a	n/a	n/a	n/a
Receivables	2.16M	2.39M	2.05M	2.39M	2.12M	3.85M	2.09M	1.57M	2.11M	1.21M	630K	800K	657K	483K	364K	1.15M	1.09M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-569K	-483K	n/a	-331K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	60.48M	73.93M	80.99M	87.36M	93.97M	73.03M	84.8M	94.57M	108.51M	71.8M	82.92M	90.5M	104.97M	118.92M	132.76M	144.39M	137.24M
Property-Plant & Equipment	1.41M	1.57M	1.72M	1.87M	2.03M	2.19M	2.32M	2.45M	2.57M	2.68M	2.85M	797K	833K	926K	1.02M	1.11M	1.2M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.41M	1.57M	1.72M	1.87M	2.03M	2.19M	2.32M	2.45M	2.57M	2.68M	2.85M	797K	833K	926K	1.02M	1.11M	1.2M
Total Assets	61.88M	75.5M	82.71M	89.23M	96M	75.23M	87.12M	97.02M	111.08M	74.48M	85.77M	91.3M	105.8M	119.85M	133.78M	145.5M	138.44M
Account Payables	2.38M	1.93M	1.63M	749K	1.73M	3.98M	1.85M	2.4M	2.85M	2.26M	2.85M	1.51M	3.06M	4.38M	4.2M	3.88M	3.41M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-1.85M	-2.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	571K	582K	567K	n/a	546K	530K	522K	n/a	n/a	487K	169K	198K	n/a	254K	259K	252K
Other Current Liabilities	1.16M	2.5M	1.05M	1.27M	824K	1.44M	2.77M	1.48M	1.08M	n/a	1.36M	1.88M	628K	n/a	762K	190K	264K
Total Current Liabilities	12.96M	8.13M	5.26M	4.57M	4.13M	7.23M	8.11M	6.81M	7.96M	6.14M	6.52M	4.26M	4.61M	6.78M	5.85M	5.33M	5.82M
Long-Term Debt	54.29M	53.35M	52.43M	51.53M	50.64M	49.77M	48.91M	48.07M	47.32M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	55.05M	54.23M	53.44M	52.69M	51.95M	51.23M	50.5M	49.8M	49.18M	2M	2.09M	384K	433K	474K	512K	573K	635K
Total Liabilities	68.01M	62.35M	58.69M	57.25M	56.08M	58.45M	58.61M	56.61M	57.15M	8.13M	8.61M	4.64M	5.04M	7.25M	6.36M	5.9M	6.45M
Total Debt	55.59M	54.8M	54.02M	53.25M	52.51M	51.77M	51.03M	50.32M	49.69M	2.49M	2.58M	553K	631K	698K	766K	832K	887K
Common Stock	288.19M	288.05M	288.01M	287.93M	287.88M	260.5M	260.5M	260.17M	260.13M	273.9M	254.94M	252.24M	251.99M	251.9M	251.77M	251.72M	251.72M
Retained Earnings	-388.31M	-367.55M	-355.18M	-345.74M	-336.38M	-326.03M	-312.42M	-297.33M	-281.29M	-266.34M	-251.53M	-236.97M	-220.33M	-206.32M	-189.44M	-175.21M	-175.98M
Comprehensive Income	n/a	n/a	n/a	53.08M	53.08M	48.46M	48.46M	48.46M	n/a	34.35M	-1.63M	-1.63M	-1.63M	-1.63M	-1.63M	-1.63M	-1.63M
Shareholders Equity	-6.12M	13.15M	24.01M	31.98M	39.92M	16.77M	28.5M	40.41M	53.94M	66.35M	77.16M	86.66M	100.76M	112.6M	127.42M	139.59M	131.99M
Total Investments	10.87M	44.38M	63.62M	69.99M	79.35M	52.24M	65.87M	55M	27M	56.95M	39.95M	23M	8M	n/a	15M	38M	58M